Literature DB >> 25957894

Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009.

Luis García-Comas1, J C Sanz Moreno2, M Ordobás Gavín3, D Barranco Ordóñez3, J García Gutiérrez3, B Ramos Blázquez2, I Rodero Garduño3.   

Abstract

The seroprevalence (SP) of measles and rubella virus antibodies is presented by age groups obtained in the IV Serosurvey of the Region of Madrid (2008-2009). The target population is composed of residents with ages ranging between 2 and 60 years in the Region of Madrid. A two-stage cluster sample is used. The SP of measles virus antibodies is 97.8% (CI 95%: 97.3-98.2). The highest SP is observed in the 2-5 year and 41-60 year age groups. The point estimate does not reach 95% in the 16-20 and 21-30 year age groups. The SP of rubella virus antibodies is 97.2% (CI 95%: 96.5-97.7). The SP is over 95% in all of the age groups. In immigrant women between the ages of 16 and 49, the SP is 95.9% (CI 95%: 93.7-97.4). The identification of groups susceptible to the measles virus in young adults could lead to outbreaks as a result of importing the virus. The circulation of the rubella virus is possible among immigrant women aged between 16 and 49 years, which could lead to the appearance of SRC cases. Epidemiological surveillance will allow the impact on the measles and rubella elimination plan to be determined in the future.
Copyright © 2015 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiological surveillance; Measles; Population surveys; Rubella; Seroprevalence

Mesh:

Substances:

Year:  2015        PMID: 25957894     DOI: 10.1016/j.jiph.2015.01.012

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  4 in total

1.  Community-wide measles outbreak in the Region of Madrid, Spain, 10 years after the implementation of the Elimination Plan, 2011-2012.

Authors:  L García Comas; M Ordobás Gavín; J C Sanz Moreno; B Ramos Blázquez; E Rodríguez Baena; E Córdoba Deorador; M García Barquero; E Gil Montalbán; A Arce Arnáez; I Rodero Garduño; D Barranco Ordóñez; J Astray Mochales
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

2.  Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1).

Authors:  Nicole Friedrich; Christina Poethko-Müller; Ronny Kuhnert; Dorothea Matysiak-Klose; Judith Koch; Ole Wichmann; Sabine Santibanez; Annette Mankertz
Journal:  Lancet Reg Health Eur       Date:  2021-06-05

3.  Comparison of rubella immunization rates in immigrant and Italian women of childbearing age: Results from the Italian behavioral surveillance system PASSI (2011-2015).

Authors:  Massimo Fabiani; Gianluigi Ferrante; Valentina Minardi; Cristina Giambi; Flavia Riccardo; Silvia Declich; Maria Masocco
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

4.  [Seroprevalence of antibodies against measles virus in Galicia: trends during the last ten years depending on age and sex].

Authors:  J J Costa-Alcalde; R Trastoy-Pena; G Barbeito-Castiñeiras; D Navarro de la Cruz; B Mejuto; A Aguilera
Journal:  Rev Esp Quimioter       Date:  2020-03-02       Impact factor: 1.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.